Search

everythinglearnresearchcommunity

for

Search:↓

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

The compound was successfully made and shows potential for treating prostate cancer.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Patients follow treatment well, but many change medicines; good information helps compliance.

Use minoxidil for hair loss treatment, and finasteride for men.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

AGA affects many, progresses differently, and early treatment is crucial.

Tissue expansion for head and neck reconstruction has good blood supply and doesn't need capsule removal, but expect temporary hair loss with normal growth resuming after 6-8 months.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Post-finasteride syndrome's existence is uncertain; more research needed.